As the coronaviral spike (S) glycoprotein is located outside the viral particle and mediates viral entry into host epithelial cells, it is undoubtedly the main target of neutralizing antibodies (NAbs) upon infection, making it the most important therapeutic target and the main focus in vaccine design. This evidence concerns the gene ART4 and infection.